Cancer clinical trials in the region Hauts-de-France
105 currently recruiting clinical trials
If you are a doctor and would like find matching clinical trials for you patients, create an account or log in
If you are a patient and would like to know if you may participate in a clinical trial, please consult your doctor so that he can send your file to a matching trial
Phase 3
Lung cancer
#NCT04603807
NSCLC (Non-Small Cell Lung Cancer)
Locally Advanced
Metastatic
ROS-1
Systemic Treatment-Naive
Immunotherapy
Chemotherapy
Targeted therapy
Car-T
Bispecific T-cell engager antibodies
Antibody Drug Conjugates (ADC)
Institut Bergonié (Bordeaux), Centre Hospitalier Universitaire de Lille (Lille), Centre Léon Bérard (Lyon), CHU de Rennes - Hôpital Pontchaillou (Rennes), Hôpital Robert Schuman - UNEOS (Vantoux)
Hoffmann-La Roche
Phase 3
Lung cancer
#NCT03774732
NSCLC (Non-Small Cell Lung Cancer)
Squamous NSCLC
Non-squamous NSCLC
Locally Advanced
Metastatic
PDL1 Positive (1% <= X < 25%)
PDL1 Positive (25% <= X < 50%)
PDL1 Positive (>= 50%)
EGFR
ALK
Institut de Cancérologie de l'Ouest - Site d'Angers (Angers ), Institut Sainte Catherine (Avignon), Institut Bergonié (Bordeaux), Centre François Baclesse (Caen ), Centre Hospitalier du docteur Jean Eric Techer (Calais) (and 26 more...)
UNICANCER
Phase 3
Lung cancer
#NCT05984277
NSCLC (Non-Small Cell Lung Cancer)
Squamous NSCLC
Non-squamous NSCLC
Metastatic
Systemic Treatment-Naive
PDL1 Negative (< 1%)
PDL1 Positive (1% <= X < 25%)
PDL1 Positive (25% <= X < 50%)
EGFR
ALK
ROS-1
Institut Godinot (Reims), Institut de Cancérologie de l'Ouest - Site d'Angers (Angers ), Centre Hospitalier d'Avignon (Avignon), Centre Hospitalier de la Côte Basque (Bayonne), Centre François Baclesse (Caen ) (and 8 more...)
AstraZeneca
Phase 3
Breast cancer
#NCT05232916
HER2 Positive
Localized
Locally Advanced
Targeted therapy
Targeted therapy
Systemic Treatment-Naive
Systemic Treatment-Naive
Hôpital NOVO (Site de Pontoise) (Pontoise), Institut Godinot (Reims), Centre Antoine Lacassagne (Nice), Institut Curie (Saint Cloud) - Hôpital René Huguenin (Saint-Cloud), Centre Hospitalier Simone Veil de Beauvais (Beauvais)
Greenwich LifeSciences, Inc.
Phase 3
Lymphoma
#NCT06091865
B cell lymphoma
Large B cell lymphoma
CD20
None
Systemic Treatment-Naive
None
Centre Hospitalier Annecy Genevois (Epagny Metz-Tessy), CHU Nîmes / Institut de cancérologie du Gard (Nîmes), Hôpital Saint Antoine AP-HP (Paris), Hôpital Saint Vincent-De-Paul (Lille), Polyclinique Bordeaux Nord Aquitaine (Bordeaux) (and 9 more...)
Regeneron Pharmaceuticals
Phase 3
Lung cancer
#NCT06097728
Mesothelium
Locally Advanced
Metastatic
Centre Hospitalier Régional Et Universitaire CHRU de Brest (Brest), Centre Hospitalier du Mans (Le Mans), Centre Hospitalier Universitaire de Strasbourg - Nouvel Hopital Civil (Strasbourg), Centre Hospitalier Universitaire de Toulouse (Toulouse), Hôpital Lyon Sud - Hospices Civils de Lyon (Pierre-Bénite) (and 7 more...)
AstraZeneca
Phase 3
Lymphoma
#NCT06284122
B cell lymphoma
Follicular lymphoma
CD20
30-50 ml/min
< 30 ml/min
Systemic Treatment-Naive
None
Allogeneic stem cell transplant
Centre Hospitalier de la Côte Basque (Bayonne), Centre Hospitalier Universitaire de Besançon (Besançon), Institut Bergonié (Bordeaux), Centre Hospitalier Métropole Savoie (Chambéry), Centre Hospitalier Universitaire de Clermont Ferrand (Clermont-Ferrand) (and 31 more...)
Organisation de recherche universitaire sur le lymphome
Phase 3
Lymphoma
#NCT05947851
B cell lymphoma
Lymphocytic lymphoma
None
Treated / Controled
1
2
3 or more
Systemic Treatment-Naive
Targeted therapy
Centre Hospitalier Universitaire de Clermont Ferrand (Clermont-Ferrand), Centre Hospitalier Départemental de Vendée (La Roche-sur-Yon), Hôpital Claude Huriez (Lille)
Merck Sharp & Dohme LLC
Phase 3
Lung cancer
#NCT06170788
NSCLC (Non-Small Cell Lung Cancer)
Metastatic
Systemic Treatment-Naive
PDL1 Positive (>= 50%)
Hôpital Saint Joseph (Marseille), Centre Hospitalier de la Côte Basque (Bayonne), Centre de Cancérologie du Grand Montpellier (Montpellier), Clinique de l'Europe d'Amiens (Amiens), Centre Hospitalier Universitaire Dupuytren (Limoges) (and 2 more...)
Merck KGaA
Phase 3
Lymphoma
#NCT06149286
B cell lymphoma
Follicular lymphoma
Marginal zone lymphoma
None
Targeted therapy
1
2
3 or more
Systemic Treatment-Naive
Hôpital Avicenne - AP-HP (Bobigny), Gustave Roussy (Villejuif), Polyclinique Bordeaux Nord Aquitaine (Bordeaux), Centre Hospitalier Universitaire de Nantes (Nantes), CHU de Rennes - Hôpital Pontchaillou (Rennes) (and 8 more...)
Regeneron Pharmaceuticals